This document is an excerpt from the EUR-Lex website
Document 32023M11168
Commission Decision of 17/08/2023 declaring a concentration to be compatible with the common market (Case No COMP/M.11168 - WARBURG PINCUS / ADVENT INTERNATIONAL / BAXTER PHARMACEUTICAL SOLUTIONS AND BAXTER ONCOLOGY) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Commission Decision of 17/08/2023 declaring a concentration to be compatible with the common market (Case No COMP/M.11168 - WARBURG PINCUS / ADVENT INTERNATIONAL / BAXTER PHARMACEUTICAL SOLUTIONS AND BAXTER ONCOLOGY) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Commission Decision of 17/08/2023 declaring a concentration to be compatible with the common market (Case No COMP/M.11168 - WARBURG PINCUS / ADVENT INTERNATIONAL / BAXTER PHARMACEUTICAL SOLUTIONS AND BAXTER ONCOLOGY) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
In force